Evogene Ltd. Logo

Evogene Ltd.

A computational biology company using AI to develop life-science products.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot

Description

Evogene Ltd. is a computational biology company that leverages artificial intelligence and big data to discover and develop novel life-science products. The company's proprietary Computational Predictive Biology (CPB) platform is designed to optimize the probability of success and reduce the time and cost of development. Evogene operates in the fields of human health, agriculture, and industrial applications. Its technology is organized into three AI-driven engines tailored for specific product types: MicroBoost AI for microbe-based products, ChemPass AI for small molecule-based products, and GeneRator AI for products based on genetic elements. The company's business model involves supporting subsidiary companies that focus on specific commercial fields, utilizing Evogene's technology to bring innovative products to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-28 16:14
20F FOR 2023
English 1.9 MB
2024-03-28 16:14
20F FOR 2023
English 36.5 KB
2024-03-20 15:59
FORM 6-K Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
English 170.9 KB
2024-03-20 15:59
FORM 6-K Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
English 36.4 KB
2024-03-19 15:59
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Fol…
English 159.5 KB
2024-03-19 15:59
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Fol…
English 36.5 KB
2024-03-13 15:59
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculan…
English 189.5 KB
2024-03-13 15:59
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculan…
English 36.5 KB
2024-03-07 14:59
Fourth Quarter and Full Year 2023 Financial Results
English 175.6 KB
2024-03-07 14:59
Fourth Quarter and Full Year 2023 Financial Results
English 36.6 KB
2024-03-06 14:59
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herb…
English 209.0 KB
2024-03-06 14:59
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herb…
English 36.4 KB
2024-03-05 14:59
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to M…
English 178.1 KB
2024-03-05 14:59
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to M…
English 36.5 KB
2024-03-01 14:59
FORM S-3, PROSPECTUS $200,000,000 of Ordinary Shares, Warrants, Rights and/or U…
English 691.2 KB

Automate Your Workflow. Get a real-time feed of all Evogene Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Evogene Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Evogene Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NANO MRNA Co.,Ltd. Logo
Biotechnology firm creating and out-licensing IP for mRNA-based therapeutics.
Japan
4571
NANOVIRICIDES, INC. Logo
Clinical-stage biopharma developing broad-spectrum, nanomedicine-based antivirals.
United States of America
NNVC
Nautilus Biotechnology, Inc. Logo
Develops a proteome analysis platform to quantify proteins at the single-molecule level.
United States of America
NAUT
NeoImmuneTech, Inc. Logo
A clinical-stage biopharma developing T cell-focused immuno-therapeutics for diseases.
United States of America
950220
Neovacs Logo
Biotech firm developing immunotherapies and investing in BioTech and MedTech.
France
ALNEV
NewAmsterdam Pharma Co N.V. Logo
A clinical-stage biopharma developing therapies for metabolic diseases with unmet needs.
United States of America
NAMS
NextGen Biomed Ltd. Logo
Develops novel therapeutic delivery systems and pain-free auto-injectors.
Israel
NXGN
NEXTURNBIOSCIENCE Co., LTD Logo
Manufacturer of CNC automatic lathes and ultra-precision components for various industries.
South Korea
089140
NFL Biosciences Logo
Biopharmaceutical company developing botanical drug candidates for addiction treatment.
France
ALNFL
NGeneBio Co., Ltd. Logo
Develops NGS-based molecular diagnostic products and software for oncology.
South Korea
354200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.